Your browser doesn't support javascript.
loading
Adjuvant therapy in hepatocellular carcinoma: the IMbrave050 trial.
Chen, Zhu; Lan, Xiang; Du, Chengyou; Xiao, Heng.
Afiliação
  • Chen Z; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China.
  • Lan X; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China.
  • Du C; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China.
  • Xiao H; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China. Electronic address: xiaohengdoctor@126.com.
Lancet ; 404(10453): 656, 2024 Aug 17.
Article em En | MEDLINE | ID: mdl-39153813
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma Hepatocelular / Neoplasias Hepáticas Idioma: En Ano de publicação: 2024 Tipo de documento: Article País de afiliação: China
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma Hepatocelular / Neoplasias Hepáticas Idioma: En Ano de publicação: 2024 Tipo de documento: Article País de afiliação: China